These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 29185789)

  • 1. Integrated Treatment of Prostaglandin E1 and Angiotensin-Converting Enzyme Inhibitor in Diabetic Kidney Disease Rats: Possible Role of Antiapoptosis in Renal Tubular Epithelial Cells.
    Mou Y; Zhang Y; Guo C; Zhao J; Zhang Z; Zhou X; Dong J; Liao L
    DNA Cell Biol; 2018 Feb; 37(2):133-141. PubMed ID: 29185789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E1 attenuates high glucose-induced apoptosis in proximal renal tubular cells by inhibiting the JNK/Bim pathway.
    Zhang YH; Zhang YQ; Guo CC; Wang LK; Cui YJ; Dong JJ; Liao L
    Acta Pharmacol Sin; 2020 Apr; 41(4):561-571. PubMed ID: 31685975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
    Koszegi S; Molnar A; Lenart L; Hodrea J; Balogh DB; Lakat T; Szkibinszkij E; Hosszu A; Sparding N; Genovese F; Wagner L; Vannay A; Szabo AJ; Fekete A
    J Physiol; 2019 Jan; 597(1):193-209. PubMed ID: 30324679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats.
    Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perindopril attenuates tubular hypoxia and inflammation in an experimental model of diabetic nephropathy in transgenic Ren-2 rats.
    Wiggins KJ; Tiauw V; Zhang Y; Gilbert RE; Langham RG; Kelly DJ
    Nephrology (Carlton); 2008 Dec; 13(8):721-9. PubMed ID: 18826488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
    Kelly DJ; Cox AJ; Tolcos M; Cooper ME; Wilkinson-Berka JL; Gilbert RE
    Kidney Int; 2002 Jan; 61(1):31-9. PubMed ID: 11786082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine RAS components in mice and people with type 1 diabetes and chronic kidney disease.
    Wysocki J; Goodling A; Burgaya M; Whitlock K; Ruzinski J; Batlle D; Afkarian M
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F487-F494. PubMed ID: 28468961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E1 for preventing the progression of diabetic kidney disease.
    Wang H; Deng JL; Yue J; Li J; Hou YB
    Cochrane Database Syst Rev; 2010 May; (5):CD006872. PubMed ID: 20464745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connectivity mapping of glomerular proteins identifies dimethylaminoparthenolide as a new inhibitor of diabetic kidney disease.
    Klein J; Caubet C; Camus M; Makridakis M; Denis C; Gilet M; Feuillet G; Rascalou S; Neau E; Garrigues L; Thillaye du Boullay O; Mischak H; Monsarrat B; Burlet-Schiltz O; Vlahou A; Saulnier-Blache JS; Bascands JL; Schanstra JP
    Sci Rep; 2020 Sep; 10(1):14898. PubMed ID: 32913274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE-inhibitor suppresses the apoptosis induced by endoplasmic reticulum stress in renal tubular in experimental diabetic rats.
    Sun HL; Sun L; Li YY; Shao MM; Cheng XY; Ge N; Lu JD; Li SM
    Exp Clin Endocrinol Diabetes; 2009 Jul; 117(7):336-44. PubMed ID: 19301230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on role of direct renin inhibitor in diabetic kidney disease.
    Dhakarwal P; Agrawal V; Kumar A; Goli KM; Agrawal V
    Ren Fail; 2014 Jul; 36(6):963-9. PubMed ID: 24678880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.
    Sen S; Kanter M; Ustundag S; Aktas C; Dogutan H; Yalcin O
    Ren Fail; 2008; 30(10):1023-33. PubMed ID: 19016156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the Ku70 and apoptosis-related proteins in experimental diabetic nephropathy.
    Tunçdemir M; Öztürk M
    Metabolism; 2016 Oct; 65(10):1466-77. PubMed ID: 27621182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.
    Kakizawa H; Itoh Y; Imamura S; Matsumoto T; Ishiwata Y; Ono Y; Yamamoto K; Kato T; Hayakawa N; Oda N; Goto Y; Goto Y; Nagasaka A; Senda T; Itoh M
    Horm Metab Res; 2004 Jul; 36(7):458-64. PubMed ID: 15305228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells.
    Gao P; Wu X; Shui H; Jia R
    J Nephrol; 2013; 26(2):289-96. PubMed ID: 22641573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease.
    Huang F; Wang Q; Guo F; Zhao Y; Ji L; An T; Song Y; Liu Y; He Y; Qin G
    EBioMedicine; 2019 Oct; 48():491-504. PubMed ID: 31629675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipo-prostaglandin E1 improves renal hypoxia evaluated by BOLD-MRI in patients with diabetic kidney disease.
    Li ZC; Cai YZ; Tang ZG; Zuo PL; Liu RB; Liu F
    Clin Imaging; 2018; 50():239-242. PubMed ID: 29689479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHOP-ASO Ameliorates Glomerular and Tubular Damage on Top of ACE Inhibition in Diabetic Kidney Disease.
    Shahzad K; Fatima S; Al-Dabet MM; Gadi I; Khawaja H; Ambreen S; Elwakiel A; Klöting N; Blüher M; Nawroth PP; Mertens PR; Michel S; Jaschinski F; Klar R; Isermann B
    J Am Soc Nephrol; 2021 Dec; 32(12):3066-3079. PubMed ID: 34479965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-135a regulates renal fibrosis in rats with diabetic kidney disease through the Notch pathway.
    Zhang LY; Wang Y; Yang YR; Shao JJ; Liang B
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1979-1987. PubMed ID: 32141566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role and mechanism of tranilast preventing the progression of tubulointerstilial fibrosis in diabetic kidney diseases].
    Luo J; Li Y; Yang Y; Li J; Sun L; Duan S; Liu H; Liu F; Liu Y; Xi Y; You Y; Li H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 38(12):1233-42. PubMed ID: 24384948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.